TRANSPARK_LONG: The Diagnostic Value of Early Transcranial Ultrasound in Patients With Extrapyramidal Diseases in a Swedish Population

Launched by REGION SKANE · Sep 4, 2023

Keywords

ClinConnect Summary

The TRANSPARK_LONG clinical trial is studying how effective early transcranial ultrasound (a type of imaging test done through the skull) is in diagnosing conditions like Parkinson's disease, tremors, and dementia in a Swedish population. The researchers want to see if the ultrasound results from when patients were first examined still match the diagnosis after a longer follow-up period. They are also interested in checking if any changes in these ultrasound results can help predict cognitive problems or dementia in the future.

To participate in this study, people need to be between 65 and 100 years old and have previously been diagnosed with parkinsonism or essential tremor before 2017. Participants will have their medical records reviewed and may be invited back for a new ultrasound and memory tests. This research aims to improve how doctors diagnose and monitor these conditions, ultimately helping patients receive better care.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with parkinsonism or essential tremor who came into contact with our clinic before 2017
• • Satisfactory transcranial bone window
• • Previous TU (clinical indication)
• Exclusion Criteria:
• • No transcranial bone window